Kim A Reiss (Reiss Binder), MD

faculty photo
Assistant Professor of Medicine at the Hospital of the University of Pennsylvania
Department: Medicine

Contact information
Division of Hematology Oncology
Perelman Center for Advanced Medicine
10th Floor, South Pavilion
Office #10-305
3400 Civic Center Blvd
Philadelphia, PA 19104
Office: 215-360-0735
Fax: 215-662-4646
Education:
BA (Psychology)
Colby College, 2002.
Post BA (Pre-Med)
Johns Hopkins University , 2003.
MD (Medicine)
Penn State College of Medicine , 2008.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

William Chapin, MD; Mark O'Hara, MD; Kim Reiss Binder, MD; Erica Carpenter, PhD: Presence of circulating tumor cells detected by immunofluorescence staining and bioinformatics approach associated with worse overall survival in locally advanced and metastatic pancreatic cancer cohorts. University of Pennsylvania Department of Medicine Research Day June 2018.

James J. Harding, Joseph P. Erinjeri, Ben Tan, Kim A. Reiss Binder, Kabir Mody, Danny N. Khalil, Hooman Yarmohammadi, Gregory, Nadolski, Marinela Capanu, Richard K. Do, Michaela Bradley, Chayma Boussayoud, Emily Valentino, William R. Jarnagin, Michael C. Soulen, Karen T. Brown, Ghassan K. Abou-Alfa.: A multicenter pilot study of nivolumab (NIVO) with drug eluting bead transarterial chemoembolization (deb-TACE) in patients (pts) with liver limited hepatocellular carcinoma (HCC). ASCO Annual Meeting, Chicago, IL June 2018.

Ofer Margalit, Ronac Mamtani, Scott Kopetz, Yu-Xiao Yang, Yaacov Richard Lawrence, Samir Abu-Gazala, Kim Anna Reiss, Talia Golan, Naama Halpern, Dan Aderka, Bruce J. Giantonio, Einat Shacham-Shmueli, Ben Boursi: Refining the use of adjuvant oxaliplatin in clinical stage II or III rectal adenocarcinoma. ASCO Annual Meeting, Chicago, IL June 2018.

Brittany Bauman, Eileen Martinez, Theresa Lawless, Lindsey Zinck, Paige Madison, Mary Fuhrer, Ursina Teitelbaum, Mark O’Hara, Charles Schneider, Peter O’Dwyer, John P. Plastaras, Rosemarie Mick, Kim A. Reiss Binder : A Randomized Study to Establish the Efficacy of Oral Cryotherapy During Oxaliplatin Infusion in Preventing Oral Thermal Hyperalgesia. University of Pennsylvania Department of Medicine Research Day June 2018.

Emily Shiffer: Pancreatic Cancer Symptoms. https://www.prevention.com/health/health-conditions/a20167615/pancreatic-cancer-symptoms/ Prevention Magazine, May 2018.

Jacob Ezra Shabason, MD; Jerry Chen; Smith Apisarnthanarax, MD; Nevena Damjanov, MD; Bruce Giantonio, MD; Arturo Loaiza-Bonilla, MD; Peter J O’Dwyer, MD; Mark O’Hara, MD; Kim A Reiss, MD; Ursina Teitelbaum, MD; Paul Wissel, MD; Jeffrey Drebin, MD, PhD; Charles Vollmer, MD; Michael Kochman, MD; Rosemarie Mick; Norge Vergara, MD; Nirag Jhala, MD; Abigail Doucette; John N Lukens, MD; John P Plastaras, MD, PhD; James M Metz, MD; Edgar Ben-Josef, MD: A Phase I Dose Escalation Trial of Nab-Paclitaxel and Fixed Dose Radiation in Patients with Unresectable or Borderline Resectable Pancreatic Cancer. Cancer Chemotherapy and Pharmacology Jan 2018 Notes: in press.

Kim A. Reiss, MD; Edgar Ben-Josef, MD; Nevena Damjanov, MD; Maarouf Hoteit, MD; Mark O’Hara, MD; Thomas Karasic, MD; Ursina Teitelbaum, MD; Charles Schneider, MD; Peter O’Dwyer, MD; Erica Carpenter, PhD; Rosemarie Mick, MS; Robert H. Vonderheide, MD, PhD: A Pilot Study of Galunisertib (LY2157299) Plus Stereotactic Body Radiotherapy (SBRT) in Advanced Hepatocellular Carcinoma (HCC). ASCO GI, San Francisco, CA Jan 2018.

Reiss KA, Yu S, Judy R, Symecko H, Nathanson, KL, Domchek SM.: Platinum-Based Treatment May Improve Overall Survival in Patients with Advanced Pancreatic Ductal Adenocarcinoma and a Germline BRCA or PALB2 Mutation: a retrospective, cohort study. JCO Precision Medicine Jan 2018.

Kim A. Reiss, MD; Kara N. Maxwell, MD, PhD; Katharine L. Nathanson, MD; Ursina Teitelbaum, MD; Mark O’Hara, MD; Peter O’Dwyer, MD; Charles Schneider, MD; Erica Carpenter, PhD; Rosemarie Mick, MS, Susan M. Domchek, MD: A single arm phase II study of rucaparib maintenance in patients with advanced pancreatic adenocarcinoma and a known deleterious BRCA1, BRCA2 or PALB2 mutation who have achieved stability on platinum therapy. ASCO GI, San Francisco, CA Jan 2018.

Ofer Margalit, Ronac Mamtani, Yu-Xiao Yang, Kim Anna Reiss, Talia Golan, Naama Halpern, Dan Aderka, Bruce J. Giantonio, Einat Shacham-Shmueli, Shimon Ben Boursi: A new look at the IDEA classification – defining novel predictive and prognostic markers in stage III colon cancer. ASCO GI, San Francisco, CA Jan 2018.

back to top
Last updated: 07/09/2018
The Trustees of the University of Pennsylvania